Why the study?
Are plasma levels of PAF acetylhydrolase (PAF-AH) lower in patients presenting with acute myocardial infarction compared to healthy controls?
Are plasma levels of PAF acetylhydrolase (PAF-AH) lower in patients presenting with acute myocardial infarction compared to healthy controls?
Decreased PAF-AH activity is observed in patients presenting with acute myocardial infarction and may represent a risk factor for the development of acute coronary syndromes.
No takes yet. Share an insight, caveat, or question.
Lower PAF-AH levels may associate with AMI; observational data leave open its role as risk marker or target.
Serebruany et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: